Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

28.88
Delayed Data
As of Feb 27
 +1.16 / +4.18%
Today’s Change
20.79
Today|||52-Week Range
37.32
-13.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues13.0M14.0M12.8M10.4M
 
 
 
 
 
Depreciation And Amortization433.0K434.0K455.0K493.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses13.1M14.6M15.5M17.0M
 
 
 
 
 
Research And Development9.1M10.8M11.5M12.5M
 
 
 
 
 
Total Operating Expenses13.6M15.1M15.9M17.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-565.0K-1.1M-3.1M-7.0M
 
 
 
 
 
Extraordinary Credit75.0K0.00--0.00
 
 
Extraordinary Charge0.00-16.0K-15.0K-13.0K
 
 
 
 
Interest Expense On Debt11.0K11.0K11.0K12.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-93.0K-642.0K-2.6M-6.5M
 
 
 
 
 
Income Taxes-1.6M-434.0K-826.0K-1.5M
 
 
 
 
 
Net Income-1.6M-1.1M-1.8M-5.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.9M19.0M19.0M19.0M
 
 
 
 
 
Shares To Calculate EPS Diluted18.9M19.0M19.0M19.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.09-$0.06-$0.09-$0.26
 
 
 
 
 
EPS Diluted-$0.09-$0.06-$0.09-$0.26